Helping Kids Cope with Cancer: Tough Questions Interviews Dan Amos, CEO of Aflac
November 05, 2018 at 04:05 AM EST
“I think I always thought I might be in the insurance business,” said Dan Amos, CEO of Aflac. “My family had been in it and it was just something I thought I might like.”
Working at Aflac since he was 14 years old, Amos and his company have been named a World’s Most Ethical Company by the Ethisphere Institute for 12 straight years. Dan, himself has been named by Harvard Business Review as one of the 100 Best Performing CEOs in the World for four consecutive years. So we sent Chloe, an 11-year-old pediatric cancer survivor, and a national ambassador for Children’s Miracle Network Hospitals® to interview Amos for a new video series, Tough Questions.
Tough Questions is an annual six-episode series that explores how companies are doing corporate social responsibility right by creating a business of purpose. The interview with Amos provides a look at Aflac’s commitment to help kids like Chloe cope with cancer. The series premiere also provides viewers with answers to questions like why Aflac uses a duck as its mascot and even provides a few canine secrets.
Catch a glimpse of the My Special Aflac Duck, now being distributed to children’s hospitals across the U.S. The My Special Aflac Duck gives kids a chance to find joy through play, helps soothe through calming heartbeats and sounds, and helps kids connect with their own treatments through medical play.
Aflac and Children’s Miracle Network Hospitals have partnered together to save and improve the lives of children. Aflac sponsors several key CMN Hospitals events throughout the year including #ChildrensHospitalsWeek, select Miracle Network Dance Marathon programs and the Dance Marathon Leadership Conference.
Learn more best practices about implementing CSR campaigns and see how other companies across the U.S. are helping to save the lives of local kids by visiting Tough Questions.
KEYWORDS: NYSE:AFL, Aflac, Children's Miracle Network Hospitals, Tough Questions, Dan Amos